Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;21(8):2871-2875.
doi: 10.1111/ajt.16636. Epub 2021 Jun 18.

Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19

Affiliations

Long-term shedding of viable SARS-CoV-2 in kidney transplant recipients with COVID-19

Ilies Benotmane et al. Am J Transplant. 2021 Aug.

Abstract

The exact duration of viable SARS-CoV-2 shedding in kidney transplant recipients (KTRs) remains unclear. Here, we retrospectively investigated this issue using cell cultures of SARS-CoV-2 RT-PCR-positive nasopharyngeal samples (n = 40) obtained from 16 KTRs with symptomatic COVID-19 up to 39 days from symptom onset. A length of viable SARS-CoV-2 shedding >3 weeks from the onset of symptoms was identified in four KTRs (25%). These results suggest that a significant proportion of KTRs can shed viable SARS-CoV-2 for at least 3 weeks, which may favor the emergence of new variants. Based on these data, we recommend prolonging the isolation of KTRs with COVID-19 until negative SARS-CoV-2 RT-PCR testing.

Keywords: clinical research/practice; complication: infectious; infection and infectious agents - viral; infectious disease; kidney transplantation/nephrology; translational research/science.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Duration of viral shedding in kidney transplant recipients (n = 16). (A) Results of viral culture in relation to the days from symptom onset for each kidney transplant recipient. A total of 40 nasopharyngeal specimens from 16 recipients were analyzed. Each sample was tested with (1) an RT-PCR-based assay targeting two different regions of the RNA-dependent RNA polymerase (RdRp) gene in accordance with the WHO technical guidance and (2) SARS-CoV-2 viral cell culture. Four patients (KTR6, KTR7, KTR8, and KTR11) were found to shed viable SARS-CoV-2 for at least 3 weeks from the onset of symptoms. (B) Presence (red dots) or absence (blue dots) of viable SARS-CoV-2 shedding (based on the results of viral culture) in relation to cycle threshold (CT) values and days after symptoms onset (DSO). KTR, kidney transplant recipient; RT-PCR, reverse transcription-polymerase chain reaction; SARS-CoV-2, severe acute respiratory distress syndrome coronavirus 2; WHO, World Health Organization [Color figure can be viewed at wileyonlinelibrary.com]

References

    1. Wölfel R, Corman VM, Guggemos W, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020;581:465–469. - PubMed
    1. Kim M-C, Cui C, Shin K-R, et al. Duration of culturable SARS-CoV-2 in hospitalized patients with Covid-19. N Engl J Med. 2021;384:671–673. - PMC - PubMed
    1. Benotmane I, Gautier-Vargas G, Wendling M-J, et al. In-depth virological assessment of kidney transplant recipients with COVID-19. Am J Transplant. 2020;20:3162–3172. - PMC - PubMed
    1. Auerswald H, de Jesus A, Seixas G, et al. First dengue virus seroprevalence study on Madeira Island after the 2012 outbreak indicates unreported dengue circulation. Parasit Vectors. 2019;12(1):103. - PMC - PubMed
    1. Basile K, McPhie K, Carter I, et al. Cell-based culture of SARS-CoV-2 informs infectivity and safe de-isolation assessments during COVID-19 [published online ahead of print 2020]. Clin Infect Dis. 10.1093/cid/ciaa1579. - DOI - PMC - PubMed

Publication types